Line 203: |
Line 203: |
| |Ruth MacKinnon PhD Victorian Cancer Cytogenetics Service Melbourne, Australia | | |Ruth MacKinnon PhD Victorian Cancer Cytogenetics Service Melbourne, Australia |
| |Complete | | |Complete |
− | |
| |
− | |
| |
− | |-
| |
− | |Myeloid/lymphoid neoplasm with PDGFRA rearrangement||Disease||Jay Alden, DO|| || || || ||FQR|| ||
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |Myeloid/lymphoid neoplasm with PDGFRB rearrangement||Disease||Christopher Sullivan, MD, MPH and Daynna J. Wolff, PhD|| || || || ||FQR|| ||
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |Myeloid/lymphoid neoplasm with FGFR1 rearrangement||Disease||Yanna Ding, MD PhD|| || || || ||FQR|| ||
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |Myeloid/lymphoid neoplasm with JAK2 rearrangement||Disease||Jessica Snider, M.D. and Daynna J. Wolff, PhD|| || || || ||FQR|| ||
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |Myeloid/lymphoid neoplasm with FLT3 rearrangement||Disease|| || || || || ||FQR|| ||
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |Myeloid/lymphoid neoplasm with ETV6::ABL1 fusion||Disease|| || || || || ||FQR|| ||
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |Myeloid/lymphoid neoplasms with other tyrosine kinase fusion genes||Disease|| || || || || ||FQR|| ||
| |
− | |
| |
− | |
| |
− | |
| |
| | | | | |
| | | | | |
Line 647: |
Line 598: |
| | | | | |
| |JH_MS | | |JH_MS |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |Myeloid/lymphoid neoplasm with PDGFRA rearrangement |
| + | |Disease |
| + | |Jay Alden, DO |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |FQR |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |Myeloid/lymphoid neoplasm with PDGFRB rearrangement |
| + | |Disease |
| + | |Christopher Sullivan, MD, MPH and Daynna J. Wolff, PhD |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |FQR |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |Myeloid/lymphoid neoplasm with FGFR1 rearrangement |
| + | |Disease |
| + | |Yanna Ding, MD PhD |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |FQR |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |Myeloid/lymphoid neoplasm with JAK2 rearrangement |
| + | |Disease |
| + | |Jessica Snider, M.D. and Daynna J. Wolff, PhD |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |FQR |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |Myeloid/lymphoid neoplasm with FLT3 rearrangement |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |FQR |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |Myeloid/lymphoid neoplasm with ETV6::ABL1 fusion |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |FQR |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |Myeloid/lymphoid neoplasms with other tyrosine kinase fusion genes |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |FQR |
| | | | | |
| | | | | |